Summary of autophagic events in trypanosomatids. DHA: Dihydroxyacetone; DTT: dithiothretiol; SBIs: sterol biosynthesis inhibitors; LPAs: lysophospholipid analogues; MBHA: Morita–Baylis–Hillman adduct.
1. Introduction
Protozoa are unicellular eukaryotes that are able to live as parasites or as free-living organisms and interact with a great variety of environments and organisms, from bacteria to man; in addition, they represent one of most important sources of parasitic diseases. Every year, more than one million people die from complications from protozoal infections worldwide [1-5]. Of the medically relevant protozoa, Trypanosomatidae and Apicomplexa constitute a substantial group including the causative agents of several human diseases such as Chagas disease, sleeping sickness, leishmaniasis, malaria and toxoplasmosis [1,5,6]. The life cycles of these parasites are highly complex, involving different hosts and different specific interactions with a variety of cells and tissues [7- 11]. Some of these parasites live in the extracellular matrix or blood of host mammals, but the majority of them infect host cells to complete their cycle. Despite the high infection and mortality rates of these protozoa, especially in low-income populations of developing regions such as Africa, Asia and the Americas, current therapies for these parasitic diseases are very limited and unsatisfactory. The development of efficient drugs is urgently necessary, as are serious public health initiatives to improve patients’ quality of life [12-16].
The Trypanosomatidae family belongs to the order Kinetoplastida and is comprised of flagellated protists characterised by the presence of the kinetoplast, a DNA-enriched portion of the mitochondrion localised close to the flagellar pocket. The most studied pathogenic trypanosomatids are the following: (a)
The Apicomplexa family encompasses a large group of protists, including approximately 5,000 known parasitic species, which are characterised by the presence of an apical complex containing a set of organelles involved in the infection process. Apicomplexan parasites infect invertebrate and vertebrate hosts, including humans and other mammals. The most serious parasitic disorder is caused by apicomplexan
Autophagy is a physiological self-degradative pathway essential for the maintenance of the metabolic balance in eukaryotes, leading to the turnover of cellular structures during both the normal cell cycle and during conditions of stress, such as starvation [21,22]. This process depends on double-membrane vesicles known as autophagosomes, which are responsible for the engulfment of macromolecules and organelles and the recycling of their components without an inflammatory response [23]. In eukaryotic cells, proteins known as Atgs contribute to the formation of autophagosomes and their targeting to lysosomes [24]. The autophagic machinery interfaces with many cellular pathways, such as that of the immune response and the inflammatory process, and acts as an inductor or suppressor of these processes [25]. Some molecules and organelles can undergo autophagy by specific proteins, such as in the selective pathway known as xenophagy, which is also observed in the degradation of intracellular pathogens [26,27]. The involvement of autophagy in this process has been demonstrated in the interactions of different pathogens with the host cells [28-30]. In protozoan infections, the role of autophagy has been debated in light of conflicting evidence presented in the literature, which tends to vary with the experimental model. Some studies suggest that parasites evade host cell defences using autophagy, while others suggest that the host uses autophagy to eliminate the pathogen [31-35]. However, there is no doubt that the autophagic machinery decisively influences the pathogenesis and virulence of protozoan infections; this machinery may therefore represent a promising target for drug discovery [36]. The autophagic process also occurs in the protozoa [37,38] and could occur in parallel to the host cell pathway, thus increasing the complexity of the phenomena. In the following sub-sections, the biology of Trypanosomatidae and Apicomplexa protozoa will be reviewed in relation to the role of autophagy during the infection of the host cells.
2. Trypanosomatids and autophagy
As previously mentioned, the transmission of neglected diseases caused by trypanosomatids (sleeping sickness, Chagas disease and leishmaniasis) depends on an insect vector, and the environmental change from one host to another is a drastic event for the protozoa. To complete its life cycle, many metabolic and morphological changes must occur for the parasite to survive in a new host [39-42]. In addition to the kinetoplast, other characteristic ultrastructural structures are present in these parasites, including a single mitochondrion, unique flagella, sub-pellicular microtubules, glycosomes, acidocalcisomes and reservosomes (the last one is present exclusively in
3. T. brucei
3.1. Role of autophagy in T. brucei
The first report on this parasite and autophagy was published in the 1970s by Vickerman and colleagues. These authors described the presence of myelin-like structures in different forms of the parasite observed by transmission electron microscopy [49, 50]. Many years later, it was suggested that the autophagic pathway is involved in the turnover of glycosomes during protozoan differentiation [51]. Glycosomes are peroxysome-like organelles that perform early glycolytic steps and are also involved in lipid metabolism. It was demonstrated that glycosome contents are altered depending on the form of the parasite, with many of these organelles being close to glysosomes during the differentiation process. A similar phenomenon was observed after nutrient deprivation of the parasite, reinforcing the fact that differentiation may cause the degradation of glycosomes by pexophagy.
Further genomic and bioinformatic analyses were performed that identified in
It is thought that many drugs may trigger autophagy in African trypanosomes. Dihydroxyacetone (DHA), spermine (snake venom) and vasoactive intestinal peptide (VIP – a neuropeptide secreted by the immune system) induce the appearance of morphological features of autophagy in
4. T. cruzi
4.1. Role of autophagy in T. cruzi
Ultrastructural evidence of autophagy in
Aside from the description of autophagosomes in all
4.2. Host cell autophagy and T. cruzi infection
Though thought to be essential for parasite success, lysosomal fusion could be involved in autophagy during host cell interaction and might contribute to the process of degradation and elimination of
5. Leishmania species
The other medically important trypanosomatids are
5.1. Role of autophagy in Leishmania sp.
Many groups have investigated autophagy cell death induced by drugs or antimicrobial peptides in various
Recently, a subunit of protein kinase A in
|
|
|
|
|
|
bloodstream trypomastigotes | autophagic cell death | DHA, neuropeptides, rapamycin, starvation | [55,58, 59] |
procyclic trypomastigotes | autophagic cell death | spermine (snake venom) | [57] | |
Autophagy-induced differentiation | rapamycin, starvation | [54,56] | ||
unfolded protein response in endoplasmic reticulum associate with autophagy | DTT | [95] | ||
|
epimastigotes, trypomastigotes | autophagic cell death | SBIs; LPAs and cetoconazole; naphthoquinones; naphthoimidazoles; MBHA; posoconazole and amiodarone | [63-65,67, 68,71,72,] |
metacyclic trypomastigotes | Autophagy-induced differentiation | starvation; differentiation medium | [37] | |
|
promastigotes, amastigotes | autophagic cell death | amiodarone; elatol; lipophilic diamine | [83,86,89] |
|
promastigotes | autophagic cell death | yangambin | [87] |
|
promastigotes | autophagic cell death | antimicrobial peptides; cryptolepine | [82,88] |
|
promastigotes, amastigotes | autophagic cell death | cathepsin inhibitors | [85] |
metacyclic promastigotes | autophagy induces differentiation | differentiation medium; starvation | [38,91] | |
|
metacyclic promastigotes | autophagy induces differentiation | differentiation medium; starvation | [90] |
5.2. Host cell autophagy and L. amazonensis infection
The connection between the endosomal/lysosomal pathway and the PV results in macromolecules being taken up by the parasite, as demonstrated in
6. Apicomplexa and autophagy
The phylum Apicomplexa comprises one of the most medically relevant groups of protists, which cause serious health and economic problems. Among these parasites,
Among the key molecules involved in early autophagy steps, Atg1/ULK complex, Atg8 and Atg9 play crucial roles in cargo selectivity and in autophagosome formation [100,101]. Unlike other cell models, in Apicomplexa protozoa, the Atg8 C-terminal appears to not undergo processing before its association with phosphatidylethanolamine (PE) in the membrane of autophagosomes, suggesting a different regulation of this Atg protein in these organisms than in mammals and fungi [102]. Using a technique to detect lipidated Atg8 in
Two important kinases have opposing roles in the autophagic process: TOR (target of rapamycin) and class III phosphatidylinositol3-kinase (PI3K) [78,103]. In well-established autophagic models, TOR and class III PI3K represent negative and positive regulators, respectively, that act through complexes with regulatory subunits orchestrated by signalling cascades. Analysis of the
7. T. gondii
In healthy adults,
7.1. Role of autophagy in T. gondii infection
Only a few studies on the
Tachyzoites divide by a process called endodyogeny, whereby two daughter cells are developed inside a mother cell and leave residual material at the end of division. During this process, autophagy might be involved in recycling the mother cell organelles, such as micronemes and rhoptries, which are synthesised de novo in the daughter cells; however the accumulation of organelles after endodyogeny has not been observed in TgATG3 knockout organisms, making other experiments necessary to confirm this hypothesis [113]. One important phenotype detected in autophagic mutants is the loss of mitochondrial integrity [102,112]. Mitophagy, which is the autophagy of mitochondria, regulates the mitochondrial number to match metabolic demand; this process represents a quality control that is necessary for the removal of damaged organelles [114]. Autophagic stimuli are able to direct the mitochondrial network of tachyzoites towards their autophagic pathway, but the molecular machinery involved in selective targeting of the organelle remains unclear [102,112]. Nutrient deprivation has been shown to be a classic stimulus for the autophagic pathway activation in a large variety of organisms [37,115]. In
The data presented here demonstrate possible functions of
While nutritional stress has been extensively used as a model for autophagy, this condition is not easily encountered in the host cells and tissues
7.2. Host cell autophagy and T. gondii infection
As previously mentioned,
Previous reports have shown that cellular immunity mediated by CD40 stimulation redirects the
So far, little has been described regarding the involvement of autophagy in the interaction of
|
|
|
|
Peritoneal Macrophages and RAW264.7 lineage |
CD40 stimulation and rapamycin | accumulation of LC3 around PV and low parasite load | [124] |
Peritoneal macrophages | INF-γ stimulation | autophagy- dependent elimination of intracellular parasite debris | [125] |
Peritoneal macrophages | INF-γ stimulation | Atg5-dependent PV membrane disruption | [32] |
bone marrow Macrophages | CD40-p21-Beclin 1 pathway | stimulation of autophagy for protection against |
[128] |
astrocytes | INF-γ stimulation |
|
[130] |
primary fibroblasts and Hela cells |
|
Induction of LC3 conjugation to PE, accumulation of vesicles containing LC3 close to PV, beclin-1 and PI3K inside the cell | [35] |
8. Plasmodium sp.
8.1. Role of autophagy in Plasmodium sp. infection
Recent publications have suggested that autophagy is involved in the differentiation of sporozoites to merosomes in hepatocytes [137,138]. The sporozoite-to-trophozoite differentiation is accompanied by the elimination of organelles unnecessary for schizogony and the production of merozoites in liver cells [137]. For example, micronemes and rhoptries are compartmentalised in the cytoplasm of sporozoites and sequestered in double-membrane structures resembling autophagosomes. In axenic conditions, the treatment of parasites with 3-methyladenine resulted in significant delay of the sporozoite differentiation process [139]. After sporozoite differentiation, Atg8 is present in autophagosomes during the replication phase, suggesting an additional independent role for this protein in autophagy [137, 138,140].
The involvement of autophagy in
Little is known about the involvement of autophagy in the
|
|
|
|
|
|
extracellular | Amino acid starvation | Basal: maintenance of life | [102] |
intracellular | Amino acid starvation and rapamycin | mitochondrial fragmentation | [111] | |
Glucose and/or pyruvate starvation | Arrested mitochondrial fragmentation | |||
|
intracellular | sporozoite to trophozoite conversion in the liver | recycling of secretory organelles | [136] |
9. Conclusion
The present chapter addresses the positive and negative regulations of the autophagic process of infected mammalian cells and the possible effects of these regulations on the
Acknowledgments
This work was supported with grants from CNPq (Universal), FAPERJ (APQ1) and IOC/FIOCRUZ.References
- 1.
Nayyar GML, Breman JG, Newton PN, Herrington J. Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa. Lancet Infectious Diseases 2012;12(6):488-96. - 2.
Soeiro MN, De Castro SL. Trypanosoma cruzi targets for new chemotherapeutic approaches. Expert Opinion on Therapeutic Targets 2009;13(1):105-21. - 3.
Kobets T, Grekov I, Lipoldova M. Leishmaniasis: prevention, parasite detection and treatment. Current Medicinal Chemistry 2012;19(10): 1443-74. - 4.
Welburn SC, Maudlin I. Priorities for the elimination of sleeping sickness. Advances in Parasitology 2012;79:299-337. - 5.
Centers for Disease Control and Prevention. Toxoplasmosis. http://www.cdc.gov/parasites/toxoplasmosis/ (accessed 17 october 2012). - 6.
World Health Organization. Working to overcome the global impact of neglected tropical diseases - First WHO report on neglected tropical diseases. Switzerland. 2010. - 7.
Bañuls AL, Hide M, Prugnolle F. Leishmania and the leishmaniases: a parasite genetic update and advances in taxonomy, epidemiology and pathogenicity in humans. Advances in Parasitology 2007;64:1-109. - 8.
Stuart K, Brun R, Croft S, Fairlamb A, Gürtler RE, McKerrow J, et al. Kinetoplastids: related protozoan pathogens, different diseases. The Journal of Clinical Investigation 2008;118(4): 1301-10. - 9.
Greenwood BM, Fidock DA, Kyle DE, Kappe SH, Alonso PL, Collins FH, et al. Malaria: progress, perils, and prospects for eradication. Journal of Clinical Investigation 2008;118(4): 1266-76. - 10.
Boyle JP, Radke JR. A history of studies that examine the interactions of Toxoplasma with its host cell: Emphasis on in vitro models. International Journal of Parasitology 2009;39(8): 903-14. - 11.
Teixeira AR, Gomes C, Lozzi SP, Hecht MM, Rosa AeC, Monteiro PS, et al. Environment, interactions between Trypanosoma cruzi and its host, and health. Cadernos de Saúde Pública 2009;25 (1): S32-44. - 12.
Nwaka S, Hudson A. Innovative lead discovery strategies for tropical diseases. Nature Reviews Drug Discovery 2006;5(11): 941-55. - 13.
Hotez PJ, Bottazzi ME, Franco-Paredes C, Ault SK, Periago MR. The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination. PLoS Neglected Tropical Diseases 2008;2(9):e300. - 14.
Le Pape P. Development of new antileishmanial drugs--current knowledge and future prospects. Journal of Enzyme Inhibition and Medicinal Chemistry 2008;23(5):708-18. - 15.
Nissapatorn V, Sawangjaroen N. Parasitic infections in HIV infected individuals: diagnostic & therapeutic challenges. The Indian Journal of Medical Research 2011;134(6): 878-97. - 16.
Hotez PJ, Savioli L, Fenwick A. Neglected tropical diseases of the Middle East and North Africa: review of their prevalence, distribution, and opportunities for control. PLoS Neglected Tropical Diseases 2012;6(2):e1475. - 17.
Lindoso JA, Lindoso AA. Neglected tropical diseases in Brazil. Revista do Instituto de Medicina Tropical de São Paulo 2009;51(5): 247-53. - 18.
Feasey N, Wansbrough-Jones M, Mabey DC, Solomon AW. Neglected tropical diseases. British Medical Bulletin 2010;93: 179-200. - 19.
World Health Organization. http://www.who.int/neglected_diseases/en/ access in November 8, 2012. - 20.
Montoya JG, Liesenfeld, O. Toxoplasmosis. Lancet 2004; 363 (9425): 1965-76. - 21.
Kiel JAKW. Autophagy in unicellular eukaryotes. Philosophical Transactions of the Royal Society 2010;365: 819-830. - 22.
Brennand A, Gualdrón-López M, Coppens I, Rigden DJ, Ginger ML, Michels PAM. Autophagy in parasitic protists: Unique features and drug targets. Molecular and Biochemical Parasitology 2011;177 (2): 83-99. - 23.
Levine B, Yuan J. Autophagy in cell death: an innocent convict? Clinical Investigation 2005;115(10):2679-88. - 24.
Mitzushima N, Yoshimori T, Ohsumi Y. The role of Atg proteins in autophagosome formation. Annual Review of Cell Developmental Biology 2011; 27: 107-32. - 25.
Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature 2011;469(7330): 323-35. - 26.
Sumpter R, Levine B. Autophagy and innate immunity: triggering, targeting and tuning. Seminars in Cell & Developmental Biology 2010;21(7): 699-711. - 27.
Kuballa P, Nolte WM, Castoreno AB, Xavier RJ. Autophagy and the immune system. Annual Review of Immunology 2012;30: 611-46. - 28.
Gutierrez MG, Master SS, Singh SB, Taylor GA, Colombo MI, Deretic V. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell. 2004;119(6): 753-66. - 29.
Deretic V, Levine B. Autophagy, immunity, and microbial adaptations. Cell Host & Microbe 2009;5(6): 527-49. - 30.
Skendros P, Mitroulis I. Host cell autophagy in immune response to zoonotic infections. Clinical & Development Immunology 2012;2012: 91052. doi:10.1155/2012/910525. (accessed 17 October 2012). - 31.
Picazarri K, Nakada-Tsukui K, Nozaki T. Autophagy during proliferation and encystation in the protozoan parasite Entamoeba invadens . Infection & Immunity. 2008;76(1): 278-88. - 32.
Zhao Z, Fux B, Goodwin M, Dunay IR, Strong D, Miller BC, et al. Autophagosome-independent essential function for the autophagy protein Atg5 in cellular immunity to intracellular pathogens. Cell host and Microbe 2008;4(5): 458-69. - 33.
Pinheiro RO, Nunes MP, Pinheiro CS, D'Avila H, Bozza PT, Takiya CM, et al. Induction of autophagy correlates with increased parasite load of Leishmania amazonensis in BALB/c but not C57BL/6 macrophages. Microbes and Infection 2009;11(2): 181-90. - 34.
Romano PS, Arboit MA, Vázquez CL, Colombo MI. The autophagic pathway is a key component in the lysosomal dependent entry of Trypanosoma cruzi into the host cell. Autophagy 2009;5(1): 6-18. - 35.
Wang Y, Weiss LM, Orlofsky A. Host cell autophagy is induced by Toxoplasma gondii and contributes to parasite growth. The Journal of biological chemistry 2009;284(3): 1694-1701. - 36.
Duszenko M, Ginger ML, Brennand A, Gualdrón-López M, Colombo MI, et al. Autophagy in protists. Autophagy. 2011;7(2): 127-58. - 37.
Alvarez VE, Kosec G, Sant'Anna C, Turk V, Cazzulo JJ, Turk B. Autophagy is involved in nutritional stress response and differentiation in Trypanosoma cruzi . The Journal of Biological Chemistry. 2008; 283(6): 3454-64. - 38.
Besteiro S, Williams RA, Morrison LS, Coombs GH, Mottram JC. Endosome sorting and autophagy are essential for differentiation and virulence of Leishmania major . The Journal of Biological Chemistry 2006;281(16): 11384-96. - 39.
Saraiva EM, Pimenta PF, Brodin TN, Rowton E, Modi GB, Sacks DL. Changes in lipophosphoglycan and gene expression associated with the development of Leishmania major inPhlebotomus papatasi . Parasitology. 1995;111 (Pt 3): 275-87. - 40.
Nolan DP, Rolin S, Rodriguez JR, Van Den Abbeele J, Pays E. Slender and stumpy bloodstream forms of Trypanosoma brucei display a differential response to extracellular acidic and proteolytic stress. European Journal of Biochemistry 2000;267(1): 18-27 - 41.
Gonçalves RL, Barreto RF, Polycarpo CR, Gadelha FR, Castro SL, Oliveira MF. A comparative assessment of mitochondrial function in epimastigotes and bloodstream trypomastigotes of Trypanosoma cruzi . Journal of Bioenergetics and Biomembranes 2011;43(6): 651-61. - 42.
Castro DP, Moraes CS, Gonzalez MS, Ratcliffe NA, Azambuja P, Garcia ES. Trypanosoma cruzi immune response modulation decreases microbiota inRhodnius prolixus gut and is crucial for parasite survival and development. PLoS One. 2012;7(5):e36591. - 43.
Berriman M, Ghedin E, Hertz-Fowler C, Blandin G, Renauld H, Bartholomeu DC, et al. The genome of the African trypanosome Trypanosoma brucei . Science 2005;309(5733): 416-22. - 44.
El-Sayed NM, Myler PJ, Bartholomeu DC, Nilsson D, Aggarwal G, Tran AN, et al. The genome sequence of Trypanosoma cruzi , etiologic agent of Chagas disease. Science 2005;309(5733): 409-15. - 45.
Ivens AC, Peacock CS, Worthey EA, Murphy L, Aggarwal G, Berriman M, et al. The genome of the kinetoplastid parasite, Leishmania major . Science 2005;309(5733): 436-42. - 46.
Rigden DJ, Herman M, Gillies S, Michels PA. Implications of a genomic search for autophagy-related genes in trypanosomatids. Biochemical Society Transactions 2005;33(Pt 5): 972-4. - 47.
Herman M, Gillies S, Michels PA, Rigden DJ. Autophagy and related processes in trypanosomatids: insights from genomic and bioinformatic analyses. Autophagy 2006;2(2): 107-18. - 48.
Hidron A, Vogenthaler N, Santos-Preciado JI, Rodriguez-Morales AJ, Franco-Paredes C, Rassi A. Cardiac involvement with parasitic infections. Clinical Microbiology Reviews 2010;23(2): 324-49. - 49.
Brown RC, Evans DA, Vickerman K. Developmental changes in ultrastructure and physiology of Trypanosoma brucei . Transactions of Royal Society of Tropical Medicine Hygiene 1972;66(2): 336-7. - 50.
Vickerman K, Tetley L. Recent ultrastructural studies on trypanosomes. Annales de la Société Belge de Médecine Tropicale 1977;57(4-5): 441-57. - 51.
Herman M, Pérez-Morga D, Schtickzelle N, Michels PA. Turnover of glycosomes during life-cycle differentiation of Trypanosoma brucei . Autophagy 2008;4(3): 294-308. - 52.
Barquilla A, Crespo JL, Navarro M. Rapamycin inhibits trypanosome cell growth by preventing TOR complex 2 formation. Proceedings of National Academy of Sciences U S A 2008;105(38): 14579-84. - 53.
Koopmann R, Muhammad K, Perbandt M, Betzel C, Duszenko M . Trypanosoma brucei ATG8: structural insights into autophagic-like mechanisms in protozoa. Autophagy 2009;5(8): 1085-91. - 54.
Li FJ, Shen Q, Wang C, Sun Y, Yuan AY, He CY. A role of autophagy in Trypanosoma brucei cell death. Cellular Microbiology 2012;14(8): 1242-56. - 55.
Uzcátegui NL, Carmona-Gutiérrez D, Denninger V, Schoenfeld C, Lang F, Figarella K, et al. Antiproliferative effect of dihydroxyacetone on Trypanosoma brucei bloodstream forms: cell cycle progression, subcellular alterations, and cell death. Antimicrobial Agents and Chemotherapy 2007;51(11): 3960-8. - 56.
Uzcátegui NL, Denninger V, Merkel P, Schoenfeld C, Figarella K, Duszenko M. Dihydroxyacetone induced autophagy in African trypanosomes. Autophagy 2007;3(6): 626-9. - 57.
Merkel P, Beck A, Muhammad K, Ali SA, Schönfeld C, Voelter W, et al. Spermine isolated and identified as the major trypanocidal compound from the snake venom of Eristocophis macmahoni causes autophagy inTrypanosoma brucei . Toxicon 2007;50(4): 457-69. - 58.
Delgado M, Anderson P, Garcia-Salcedo JA, Caro M, Gonzalez-Rey E. Neuropeptides kill African trypanosomes by targeting intracellular compartments and inducing autophagic-like cell death. Cell Death and Differetiation 2009;16(3): 406-16. - 59.
Denninger V, Koopmann R, Muhammad K, Barth T, Bassarak B, Schönfeld C, et al. Kinetoplastida: model organisms for simple autophagic pathways? Methods in Enzymology 2008;451: 373-408. - 60.
Zhang Y, Qi H, Taylor R, Xu W, Liu LF, Jin S. The role of autophagy in mitochondria maintenance: characterization of mitochondrial functions in autophagy-deficient S. cerevisiae strains. Autophagy 2007;3(4): 337-46. - 61.
Chen Y, Gibson SB. Is mitochondrial generation of reactive oxygen species a trigger for autophagy? Autophagy 2008;4(2): 246-8. - 62.
Scherz-Shouval R, Elazar Z. Regulation of autophagy by ROS: physiology and pathology. Trends in BiochemicalSciences 2011;36(1): 30-8. - 63.
Braga MV, Magaraci F, Lorente SO, Gilbert I, de Souza W. Effects of inhibitors of Delta24(25)-sterol methyl transferase on the ultrastructure of epimastigotes of Trypanosoma cruzi . Microscopy and Microanalysis 2005;11(6): 506-15. - 64.
Santa-Rita RM, Lira R, Barbosa HS, Urbina JA, de Castro SL. Anti-proliferative synergy of lysophospholipid analogues and ketoconazole against Trypanosoma cruzi (Kinetoplastida: Trypanosomatidae): cellular and ultrastructural analysis. The Journal of Antimicrobial Chemotherapy 2005;55(5): 780-4. - 65.
Menna-Barreto RF, Corrêa JR, Pinto AV, Soares MJ, de Castro SL. Mitochondrial disruption and DNA fragmentation in Trypanosoma cruzi induced by naphthoimidazoles synthesized from beta-lapachone. Parasitology Research 2007;101(4): 895-905. - 66.
Menna-Barreto RF, Corrêa JR, Cascabulho CM, Fernandes MC, Pinto AV, Soares MJ, et al. Naphthoimidazoles promote different death phenotypes in Trypanosoma cruzi . Parasitology 2009;136(5): 499-510. - 67.
Fernandes MC, Da Silva EN, Pinto AV, De Castro SL, Menna-Barreto RF. A novel triazolic naphthofuranquinone induces autophagy in reservosomes and impairment of mitosis in Trypanosoma cruzi . Parasitology 2012;139(1): 26-36. - 68.
Veiga-Santos P, Barrias ES, Santos JF, de Barros Moreira TL, de Carvalho TM, Urbina JA, et al. Effects of amiodarone and posaconazole on the growth and ultrastructure of Trypanosoma cruzi. International Journal of Antimicrobial Agents 2012;40(1): 61-71. - 69.
Menna-Barreto RF, Salomão K, Dantas AP, Santa-Rita RM, Soares MJ, Barbosa HS, et al. Different cell death pathways induced by drugs in Trypanosoma cruzi : an ultrastructural study. Micron 2009;40(2): 157-68. - 70.
DaRocha WD, Otsu K, Teixeira SM, Donelson JE. Tests of cytoplasmic RNA interference (RNAi) and construction of a tetracycline-inducible T7 promoter system in Trypanosoma cruzi . Molecular and Biochemical Parasitolology 2004;133(2): 175-86. - 71.
Sandes JM, Borges AR, Junior CG, Silva FP, Carvalho GA, Rocha GB, et al. 3-Hydroxy-2-methylene-3-(4-nitrophenylpropanenitrile): A new highly active compound against epimastigote and trypomastigote form of Trypanosoma cruzi . Bioorganic Chemistry 2010;38(5): 190-5. - 72.
Benitez D, Pezaroglo H, Martínez V, Casanova G, Cabrera G, Galanti N, et al. Study of Trypanosoma cruzi epimastigote cell death by NMR-visible mobile lipid analysis. Parasitology 2012 139(4): 506-15. - 73.
Soares MJ, Souto-Padrón T, De Souza W. Identification of a large pre-lysosomal compartment in the pathogenic protozoon Trypanosoma cruzi. Journal of Cell Science 1992;102 (Pt 1): 157-67. - 74.
Soares MJ. The reservosome of Trypanosoma cruzi epimastigotes: an organelle of the endocytic pathway with a role on metacyclogenesis. Memórias do Instituto Oswaldo Cruz 1999;94 (1): 139-41. - 75.
Figueiredo RC, Rosa DS, Soares MJ. Differentiation of Try panosoma cruzi epimastigotes: metacyclogenesis and adhesion to substrate are triggered by nutritional stress. The Journal of Parasitology 2000;86(6): 1213-8. - 76.
Alvarez VE, Kosec G, Sant Anna C, Turk V, Cazzulo JJ, Turk B. Blocking autophagy to prevent parasite differentiation: a possible new strategy for fighting parasitic infections? Autophagy 2008;4(3): 361-3 - 77.
Braga MV, de Souza W. Effects of protein kinase and phosphatidylinositol-3 kinase inhibitors on growth and ultrastructure of Trypanosoma cruzi . FEMS Microbiology Letters 2006;256(2): 209-16. - 78.
Petiot A, Ogier-Denis E, Blommaart EF, Meijer AJ, Codogno P. Distinct classes of phosphatidylinositol 3'-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells. The Journal of Biological Chemistry. 2000; 275(2): 992-8. - 79.
Romano PS, Cueto JA, Casassa AF, Vanrell MC, Gottlieb RA, Colombo MI. Molecular and cellular mechanisms involved in the Trypanosoma cruzi /host cell interplay. IUBMB Life 2012;64(5): 387-96. - 80.
Martins RM, Alves RM, Macedo S, Yoshida N. Starvation and rapamycin differentially regulate host cell lysosome exocytosis and invasion by Trypanosoma cruzi metacyclic forms. Cellular Microbiology 2011;13(7): 943-54. - 81.
Maeda FY, Alves RM, Cortez C, Lima FM, Yoshida N. Characterization of the infective properties of a new genetic group of Trypanosoma cruzi associated with bats. Acta Tropica 2011;120(3): 231-7. - 82.
Bera A, Singh S, Nagaraj R, Vaidya T. Induction of autophagic cell death in Leishmania donovani by antimicrobial peptides. Molecular and Biochemichal Parasitology 2003;127(1): 23-35. - 83.
Dos Santos AO, Veiga-Santos P, Ueda-Nakamura T, Filho BP, Sudatti DB, Bianco EM, et al. Effect of elatol, isolated from red seaweed Laurencia dendroidea , onLeishmania amazonensis . Marine Drugs 2010;8(11): 2733-43. - 84.
Santos AO, Santin AC, Yamaguchi MU, Cortez LE, Ueda-Nakamura T, Dias-Filho BP, et al. Antileishmanial activity of an essential oil from the leaves and flowers of Achillea millefolium . Annals of Tropical Medicine and Parasitology 2010;104(6): 475-83. - 85.
Schurigt U, Schad C, Glowa C, Baum U, Thomale K, Schnitzer JK, et al. Aziridine-2,3-dicarboxylate-based cysteine cathepsin inhibitors induce cell death in Leishmania major associated with accumulation of debris in autophagy-related lysosome-like vacuoles. Antimicrobial Agents and Chemotherapy 2010;54(12): 5028-41. - 86.
de Macedo-Silva ST, de Oliveira Silva TL, Urbina JA, de Souza W, Rodrigues JC. Antiproliferative, Ultrastructural, and Physiological Effects of Amiodarone on Promastigote and Amastigote Forms of Leishmania amazonensis . Molecular Biology International 2011; doi: 10.4061/2011/876021 (accessed 17 October 2012). - 87.
Monte Neto RL, Sousa LM, Dias CS, Barbosa Filho JM, Oliveira MR, Figueiredo RC. Morphological and physiological changes in Leishmania promastigotes induced by yangambin, a lignan obtained fromOcotea duckei . Experimental Parasitology 2011;127(1):215-21. - 88.
Sengupta S, Chowdhury S, Bosedasgupta S, Wright CW, Majumder HK. Cryptolepine-Induced Cell Death of Leishmania donovani Promastigotes Is Augmented by Inhibition of Autophagy. Molecular Biological International 2011;2011: 187850. - 89.
Silva AL, Adade CM, Shoyama FM, Neto CP, Padrón TS, de Almeida MV, et al. In vitro leishmanicidal activity of N-dodecyl-1,2-ethanediamine. Biomedicine and Pharmacotherapy 2012;66(3): 180-6. - 90.
Williams RA, Tetley L, Mottram JC, Coombs GH. Cysteine peptidases CPA and CPB are vital for autophagy and differentiation in Leishmania mexicana . Molecular Microbiology 2006;61(3): 655-74. - 91.
] Besteiro S, Williams RA, Coombs GH, Mottram JC. Protein turnover and differentiation in Leishmania . International Journal for Parasitology 2007;37(10): 1063-75. - 92.
Bhattacharya A, Biswas A, Das PK. Identification of a protein kinase A regulatory subunit from Leishmania having importance in metacyclogenesis through induction of autophagy. Molecular Microbiology 2012;83(3): 548-64. - 93.
Williams RAM, Woods KL, Juliano L, Mottram JC, Coombs GH. Characterisation of unusual families of ATG8-like proteins and ATG12 in the protozoan parasite Leishmania major . Autophagy 2009;5(2): 159-172. - 94.
Williams RAM, Smith TK, Cull B, Mottram JC, Coombs GH. ATG5 is Essential for ATG8-Dependent Autophagy and Mitochondrial Homeostasis in Leishmania major . Plos Pathogens 2012; 8 (5): 1-14. - 95.
Goldshmidt H, Matas D, Kabi A, Carmi S, Hope R, Michaeli S. Persistent ER stress induces the spliced leader RNA silencing pathway (SLS), leading to programmed cell death in Trypanosoma brucei . PLoS Pathogens 2010;6(1):e1000731. - 96.
Schaible UE, Schlesinger PH, Steinberg TH, Mangel WF, Kobayashi T, Russell DG. Parasitophorous vacuoles of Leishmania mexicana acquire macromolecules from the host cell cytosol via two independent routes. Journal of Cell Science 1999;112( Pt 5): 681-93. - 97.
Cyrino LT, Araújo AP, Joazeiro PP, Vicente CP, Giorgio S. In vivo andin vitro Leishmania amazonensis infection induces autophagy in macrophages. Tissue & Cell 2012; doi: http://dx.doi.org/10.1016/j.tice.2012.08.003 (accessed 17 October 2012). - 98.
Mitroulis I, Kourtzelis I, Papadopoulos VP, Mimidis K, Speletas M, Ritis K. In vivo induction of the autophagic machinery in human bone marrow cells duringLeishmania donovani complex infection. Parasitology International 2009;58(4):475-7. - 99.
Besteiro S. Which roles for autophagy in Toxoplasma gondii and related apicomplexan parasites? Molecular and Biochemical Parasitology 2012;184: 1-8. - 100.
Xie Z, Nair U, Klionsky DJ. Atg8 controls phagophore expansion during autophagosome formation. Molecular biology of the cell 2008;19(8): 3290-8. - 101.
Shvets E, Fass E, Scherz-Shouval R, Elazar Z. The N-terminus and Phe52 residue of LC3 recruit p62/SQSTM1 into autophagosomes. Journal of cell science 2008;121(Pt 16): 2685-95. - 102.
Besteiro S, Brooks CF, Striepen B, Dubremetz JF. Autophagy protein Atg3 is essential for maintaining mitochondrial integrity and for normal intracellular development of Toxoplasma gondii tachyzoites. PLoS pathogens2011;7(12): e1002416. - 103.
Diaz-Troya S, Perez-Perez ME, Florencio FJ, Crespo JL. The role of TOR in autophagy regulation from yeast to plants and mammals. Autophagy 2008;4(7): 851-65. - 104.
Rigden DJ, Michels PA, Ginger ML. Autophagy in protists: Examples of secondary loss, lineage-specific innovations, and the conundrum of remodeling a single mitochondrion. Autophagy 2009;5(6): 784-94. - 105.
Dubey JP, Jones JL. Toxoplasma gondii infection in humans and animals in the United States. International journal for parasitology 2008;38(11): 1257-78. - 106.
Furtado JM, Smith JR, Belfort R Jr., Gattey D, Winthrop KL. Toxoplasmosis: a global threat. Journal of global infectious diseases 2011;3(3): 281-4. - 107.
Mordue DG, Hakansson S, Niesman I, Sibley, LD. Toxoplasma gondii resides in a vacuole that avoids fusion with host cell endocytic and exocytic vesicular trafficking pathways. Experimental parasitology 1999;92(2): 87-99. - 108.
Sullivan WJ Jr., Jeffers V. Mechanisms of Toxoplasma gondii persistence and latency. FEMS microbiology reviews 2012;36(3): 717-33. - 109.
Ambroise-Thomas P, Pelloux H. Toxoplasmosis - congenital and in immunocompromised patients: a parallel. Parasitology today 1993;9(2): 61-3. - 110.
Mele A, Paterson PJ, Prentice HG., Leoni P, Kibbler CC. Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature. Bone marrow transplantation 2002;29(8): 691-8. - 111.
Innes EA. A brief history and overview of Toxoplasma gondii . Zoonoses and public health 2010;57(1): 1-7. - 112.
Ghosh D, Walton JL, Roepe PD, Sinai AP. Autophagy is a cell death mechanism in Toxoplasma gondii . Cellular microbiology 2012;14(4): 589-607. - 113.
Besteiro S. Role of ATG3 in the parasite Toxoplasma gondii : Autophagy in an early branching eukaryote. Autophagy 2012;8(3): 435-7. - 114.
Youle RJ, Narendra DP. Mechanisms of mitophagy. Nature reviews Molecular cell biology 2011;12(1): 9-14. - 115.
Meijer AJ, Codogno P. Regulation and role of autophagy in mammalian cells. The international journal of biochemistry and cell biology 2004;36(12): 2445-62. - 116.
Dubey JP, Frenkel JK. Cyst-induced toxoplasmosis in cats. The Journal of protozoology 1972;19(1): 155-7. - 117.
Dubey JP, Frenkel JK. Experimental toxoplasma infection in mice with strains producing oocysts. The Journal of parasitology 1973; 59(3): 505-12. - 118.
Dubey JP. Feline toxoplasmosis and coccidiosis: a survey of domiciled and stray cats. Journal of the American Veterinary Medical Association 1973; 162(10): 873-7. - 119.
Denton D, Nicolson S, Kumar S. Cell death by autophagy: facts and apparent artefacts. Cell death and differentiation 2012;19(1): 87-95. - 120.
Yahiaoui B, Dzierszinski F, Bernigaud A, Slomianny C, Camus D, Tomavo S. Isolation and characterization of a subtractive library enriched for developmentally regulated transcripts expressed during encystation of Toxoplasma gondii . Molecular and biochemical parasitology 1999;99(2): 223-35. - 121.
Pfefferkorn ER. Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proceedings of the National Academy of Sciences of the United States of America 1984;81(3): 908-12. - 122.
Pfefferkorn ER, Eckel M, Rebhun S. Interferon-gamma suppresses the growth of Toxoplasma gondii in human fibroblasts through starvation for tryptophan. Molecular and biochemical parasitology 1986;20(3): 215-24. - 123.
Black MW, Boothroyd JC. Lytic cycle of Toxoplasma gondii . Microbiology and molecular biology reviews 2000;64(3): 607-23. - 124.
Andrade RM, Wessendarp M, Gubbels MJ, Striepen B, Subauste, CS. CD40 induces macrophage anti- Toxoplasma gondii activity by triggering autophagy-dependent fusion of pathogen-containing vacuoles and lysosomes. The Journal of clinical investigation 2006;116(9): 2366-77. - 125.
Ling Y M, Shaw MH, Ayala C, Coppens I, Taylor GA, Ferguson DJ, et al.. Vacuolar and plasma membrane stripping and autophagic elimination of Toxoplasma gondii in primed effector macrophages. The Journal of experimental medicine 2006;203(9): 2063-271. - 126.
Subauste CS, Andrade RM, Wessendarp M. CD40-TRAF6 and autophagy-dependent anti-microbial activity in macrophages. Autophagy 2007;3(3): 245-8. - 127.
Zhao Y, Wilson D, Matthews S, Yap GS. Rapid elimination of Toxoplasma gondii by gamma interferon-primed mouse macrophages is independent of CD40 signaling. Infection and immunity 2007;75(10): 4799-803. - 128.
Portillo JA, Okenka G, Reed E, Subauste A, Van Grol J, Gentil K, et al. The CD40-autophagy pathway is needed for host protection despite IFN-Gamma-dependent immunity and CD40 induces autophagy via control of P21 levels. PLoS One 2010;5(12): e14472. - 129.
Bogdan C, Rollinghoff M. How do protozoan parasites survive inside macrophages? Parasitology Today 1999;15(1): 22-8. - 130.
Halonen SK. Role of autophagy in the host defense against Toxoplasma gondii in astrocytes. Autophagy 2009;5(2): 268-9. - 131.
Cox-Singh J, Davis TM, Lee KS, Shamsul SS, Matusop A, Ratnam S, et al. Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening. Clinical infectious diseases 2008;46(2): 165-71. - 132.
Marchand RP, Culleton R, Maeno Y, Quang NT, Nakazawa S. Co-infections of Plasmodium knowlesi, P. falciparum , andP. vivax among Humans and Anopheles dirus Mosquitoes, Southern Vietnam. Emerging infectious diseases 2011;17(7): 1232-9. - 133.
William T, Menon J, Rajahram G, Chan L, Ma G, Donaldson S, et al. Severe Plasmodium knowlesi malaria in a tertiary care hospital, Sabah, Malaysia. Emerging infectious diseases 2011;17(7): 1248-55. - 134.
Frevert U, Engelmann S, Zougbede S, Stange J, Ng B, Matuschewski K, et al. Intravital observation of Plasmodium berghei sporozoite infection of the liver. PLoS biology 2005;3(6): e192. - 135.
Amino R, Thiberge S, Martin B, Celli S, Shorte S, Frischknecht F, et al. Quantitative imaging of Plasmodium transmission from mosquito to mammal. Nature Medicine 2006;12(2): 220-4. - 136.
Sturm A, Amino R, van de Sand C, Regen T, Retzlaff S, Rennenberg A, et al. Manipulation of host hepatocytes by the malaria parasite for delivery into liver sinusoids. Science 2006;313(5791): 1287-90. - 137.
Jayabalasingham B, Bano N, Coppens I. Metamorphosis of the malaria parasite in the liver is associated with organelle clearance. Cell Research 2010; 20: 1043-1059. - 138.
Coppens I. Metamorphoses of malaria: the role of autophagy in parasite differentiation. Essays in biochemistry 2011;51: 127-36. - 139.
Vaid A, Ranjan R, Smythe WA, Hoppe HC, Sharma P. PfPI3K, a phosphatidylinositol-3 kinase from Plasmodium falciparum , is exported to the host erythrocyte and is involved in hemoglobin trafficking. Blood 2010;115(12): 2500-7. - 140.
Kitamura K, Kishi-Itakura C, Tsuboi T, Sato S, Kita K, Ohta N, Mizushima N. Autophagy-Related Atg8 Localizes to the Apicoplast of the Human Malaria Parasite Plasmodium falciparum. Plos one 2012;7(8): 1-10.